Open Access · CC BY 4.0
Mucormycosis: COVID-19 and Corticosteroids
The University of Louisville Journal of Respiratory Infections · 14.04.2022 · 6 (1)
DOI: 10.55504/2473-2869.1233 ↗Kurz gefasst
Fachartikel in der Zeitschrift The University of Louisville Journal of Respiratory Infections, online erschienen am 14.04.2022. Verfasst von Mittal Savaliya und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Savaliya, M., Jha, N., & Lippmann, S. B. (2022). Mucormycosis: COVID-19 and Corticosteroids. The University of Louisville Journal of Respiratory Infections, 6(1). https://doi.org/10.55504/2473-2869.1233
Vancouver
Savaliya M, Jha N, Lippmann SB. Mucormycosis: COVID-19 and Corticosteroids. The University of Louisville Journal of Respiratory Infections. 2022;6(1). doi:10.55504/2473-2869.1233
BibTeX
@article{Savaliya2022,
author = {Savaliya, Mittal and Jha, Nivedita and Lippmann, Steven B},
title = {Mucormycosis: COVID-19 and Corticosteroids},
journal = {The University of Louisville Journal of Respiratory Infections},
year = {2022},
volume = {6},
number = {1},
doi = {10.55504/2473-2869.1233}
}
EUVIMED